Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2022-04-28 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
独立董事2021年度述职报告（刘霄仑）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2021 Annual Work Report" for Yingkang Life Technology Co., Ltd. It details the independent director's attendance at board and shareholder meetings, opinions on various company matters, committee work, investigations, investor protection efforts, and training during the 2021 fiscal year. The content is a detailed report of the independent director's activities and responsibilities over the year, not an announcement or a brief summary. It does not contain financial statements or earnings data, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a proxy solicitation or voting results announcement. It is a management-related report focusing on board activities and governance oversight by an independent director. Therefore, the best fitting category is Board/Management Information (MANG). The document length (8547 characters) supports it being a full report rather than a brief announcement.
2022-04-28 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 23rd meeting of the 5th Board of Directors of 盈康生命科技股份有限公司. It includes approvals of the 2021 Annual Report, financial statements, internal control reports, social responsibility report, profit distribution plan, appointment of auditors, and other governance matters. It references the 2021 Annual Report and other reports that are disclosed separately on the official disclosure platform (巨潮资讯网). The document is not the Annual Report itself but a board meeting resolution announcement that discusses and approves various reports and proposals to be submitted to the 2021 Annual General Meeting. It also includes management and independent directors' opinions and voting results. The document length is over 13,000 characters and contains substantive content about board decisions, but it is not a full financial report or earnings release. It is best classified as Board/Management Information (MANG) because it primarily reports on board meeting resolutions and management reports rather than the reports themselves or their publication announcements.
2022-04-28 Chinese
关于重庆华健友方医院有限公司2021年12月31日股东权益价值减值测试报告的审核报告
Audit Report / Information Classification · 95% confidence The document is an audit report on an impairment test related to asset restructuring and compensation period for a specific asset injection. It is issued by a certified public accounting firm and includes detailed audit procedures, management responsibilities, and audit conclusions. The document references compliance with regulations from the China Securities Regulatory Commission and contains no full annual or interim financial statements but focuses on the audit of a specific impairment test report. The document length is 3498 characters, which is relatively short but contains substantive audit content rather than just an announcement or certification. Therefore, it fits best under the category of Audit Report / Information (AR), as it is a standalone audit report on impairment testing, not a full annual report or a simple announcement. FY 2021
2022-04-28 Chinese
关于苏州广慈肿瘤医院有限公司2021年度承诺业绩实现情况的鉴证报告
Audit Report / Information Classification · 95% confidence The document is a verification report (鉴证报告) on the performance commitment realization for the year 2021 related to Suzhou Guangci Oncology Hospital Co., Ltd. It is prepared by an accounting firm and references compliance with the China Securities Regulatory Commission's rules on major asset restructuring. The document includes detailed explanations of the performance commitments, agreements, and compensation mechanisms related to a transaction involving acquisition of 100% equity. The document is titled as a "verification report" and contains an auditor's opinion on the special explanation of performance commitment realization. It is not a full annual report (10-K), nor an interim report, nor a simple announcement. It is a standalone audit-related verification report focusing on a specific aspect of the company's financial commitments and performance related to a major asset restructuring. The document length is 3385 characters, which is relatively short but contains substantive audit verification content. Therefore, it fits best under the category of Audit Report / Information (AR). FY 2021
2022-04-28 Chinese
2021年年度报告
Annual Report Classification · 100% confidence The document is titled "盈康生命科技股份有限公司 2021 年年度报告全文" which translates to "INKON Life Technology Co., Ltd. 2021 Annual Report Full Text." It contains detailed sections including company overview, financial data, management discussion and analysis, governance, environmental and social responsibility, and full financial statements. The document length is 15,000 characters, indicating a comprehensive report rather than a brief announcement. It includes audited financial data, management analysis, and extensive disclosures typical of an official annual report. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2021
2022-04-28 Chinese
安信证券股份有限公司关于公司2022年度日常关联交易预计的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from Anxin Securities regarding the 2022 anticipated daily related-party transactions of Yingkang Life Technology Co., Ltd. It includes extensive financial data, transaction categories, amounts, related parties, pricing principles, contract signing status, and explanations of the transactions' impact on the company. The content focuses on related-party transactions, their approval processes, and compliance with Shenzhen Stock Exchange rules. There is no indication that this is an annual report, earnings release, or a simple announcement. The document is substantive, detailed, and appears to be a formal audit or verification opinion on related-party transactions, which aligns with the category of Audit Report / Information (AR). It is not a regulatory filing or announcement, nor a management or board change notice. Therefore, the best fit is Audit Report / Information (AR). FY 2022
2022-04-28 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.